title: Dasatinib induces a response in malignant thymoma.
authors.forename: Charles
authors.initials: C
authors.lastname: Chuah
authors.forename: Tse Hui
authors.initials: TH
authors.lastname: Lim
authors.forename: Alvin Soon Tiong
authors.initials: AS
authors.lastname: Lim
authors.forename: Sim Leng
authors.initials: SL
authors.lastname: Tien
authors.forename: Chong Hee
authors.initials: CH
authors.lastname: Lim
authors.forename: Richie
authors.initials: R
authors.lastname: Soong
authors.forename: Francis
authors.initials: F
authors.lastname: Lee
authors.forename: Yeh Ching
authors.initials: YC
authors.lastname: Linn
authors.forename: Yeow Tee
authors.initials: YT
authors.lastname: Goh
authors.forename: Foong Koon
authors.initials: FK
authors.lastname: Cheah
authors.forename: Alwin Hwai Liang
authors.initials: AH
authors.lastname: Loh
mesh_terms: D000069439:Dasatinib; D006801:Humans; D008297:Male; D011743:Pyrimidines / Q000627:therapeutic use*; D012074:Remission Induction; D013844:Thiazoles / Q000627:therapeutic use*; D013945:Thymoma / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D013953:Thymus Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D014057:Tomography, X-Ray Computed
chemical_list: D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib